✦ LIBER ✦

Second-line treatment of non-small cell lung carcinomas with vinorelbine and ifosfamide: preliminary results of a phase II trial of the Greek Cooperative Group for Lung Cancer

✍ Scribed by Papadakis, E; Kourousis, Ch; Androulakis, N; Agelaki, S; Apostolopoulou, F; Palamidas, F; Rapti, A; Sarra, E; Tziani, V; Bania, E; Agelidou, A; Gianakakis, Th; Kandilis, K; Adravanis, A; Apostolaki, F; Georgoulias, V

Book ID: 118575473
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 239 KB
Volume: 21
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(98)90074-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

nCombination chemotherapy with docetaxel

nCombination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: A multicenter phase II study of the Greek Cooperative Group for Lung Cancer

✍ Georgoulias, Vassilis; Androulakis, Nikos; Bouros, Demosthenis; Kouroussis, Char 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Preliminary results of a phase II random

Preliminary results of a phase II randomized trial of docetaxel vs vinorelbine as second-line treatment in previously cisplatin-treated advanced non-small cell lung cancer (NSCLC)

✍ Marangolo, M; Cognetti, F; Di Costanzo, F; Selvaggi, G; Scagliotti, G.V 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Combination of cisplatin, ifosfamide and

Combination of cisplatin, ifosfamide and vinorelbine in phase II trial in advanced non-small cell lung cancer (NSCLC)

✍ Barón, FJ; Ceuva, JF; Vázquez, F; Candamio, S; Calvo, M; Menéndez, MD; Irigoyen, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 252 KB

232 Cisplatin, ifosfamide and vinorelbin

232 Cisplatin, ifosfamide and vinorelbine with granulocyte colony-stimulating factor (G-CSF) as a treatment of advanced non small cell lung cancer (NSCLC). Preliminary results of a phase II study

✍ Pronzato, P.; Ghio, E.; Pensa, F.; Stagnaro, A.; Vaira, F.; Vigani, A. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Gemcitabine and vinorelbine in the secon

Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients : A Minnie Pearl Cancer Research Network Phase II trial

✍ John D. Hainsworth; Howard A. Burris III; Sharlene Litchy; Joan B. Erland; Jerem 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

## BACKGROUND. Second-line chemotherapy for patients with nonsmall cell lung carcinoma has been ineffective due to the lack of activity of older agents following platinum-based therapy. This Phase II trial evaluated the feasibility, toxicity, and efficacy of two active new agents, gemcitabine and v

Second-line with vinorelbine in the week

Second-line with vinorelbine in the weekly monochemotherapy for the treatment of advanced non small cell lung cancer (NSCLC)

✍ Santoro, A.; Maiorino, L.; Santoro, M. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 130 KB